- Home
- KZIA
as 01-17-2025 4:00pm EST
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
| Founded: | 1994 | Country: | Australia |
| Employees: | N/A | City: | NEW SOUTH WALES 2113 |
| Market Cap: | 7.8M | IPO Year: | 1999 |
| Target Price: | $20.00 | AVG Volume (30 days): | 116.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -6.78 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.39 - $15.80 | Next Earning Date: | 11-15-2024 |
| Revenue: | $1,655,324 | Revenue Growth: | 248000.00% |
| Revenue Growth (this year): | 806.89% | Revenue Growth (next year): | N/A |
Latest Kazia Therapeutics Limited News
KZIA Breaking Stock News: Dive into KZIA Ticker-Specific Updates for Smart Investing
PR Newswire
5 days ago
Kazia Therapeutics Announces Closing of $2.0 Million Registered Direct Offering
TipRanks
8 days ago
Kazia Therapeutics to sell 1.33M ADS at $1.50 in registered direct offering
MT Newswires
9 days ago
Kazia Therapeutics Launches $2 Million Registered Direct Offering
PR Newswire
9 days ago
Kazia Therapeutics Announces $2.0 Million Registered Direct Offering
Benzinga
19 days ago
Why Is Brain Cancer-Focused Kazia Therapeutics Stock Trading Lower On Tuesday?
MT Newswires
19 days ago
Update: Kazia Therapeutics Shares Drop After FDA Derails Fast Track of Potential Brain Cancer Drug
MT Newswires
19 days ago
Kazia Therapeutics Shares Drop After FDA Derails Fast Track of Potential Brain Cancer Drug
PR Newswire
19 days ago
Kazia Therapeutics Provides Update on Paxalisib Regulatory Pathway Following Type C Meeting with FDA
Compare KZIA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "KZIA Kazia Therapeutics Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.